Poly[(μ(2)-2-hydr­oxy-2-methyl­propionato-κ(3) O (1),O (2):O (1′))(μ(2)-2-hydr­oxy-2-methyl­propionato-κ(2)...

por Yoshimura, Takashi, Kikunaga, Hidetoshi, Shinohara, Atsushi
Publicado em 2009

Discontinuation of simvastatin leads to a rebound phenomenon and results in immediate peri‐implant bone loss

por Li, Xianqi, Wu, Feng, Zhang, Yiming, Yang, Jing, Shinohara, Atsushi, Kagami, Hideaki
Publicado no Clin Exp Dent Res (2016)

Quantitative measurement of (219)Rn radioactivity in exhaled breath from patients with bone metastasis of castration-resistant prostate cancer treated with (223)RaCl(2)

por Ooe, Kazuhiro, Watabe, Tadashi, Kamiya, Takashi, Yoshimura, Takashi, Hosono, Makoto, Shinohara, Atsushi, Hatazawa, Jun
Publicado no EJNMMI Phys (2019)

Synthesis and Photoluminescence of Tetracyanidonitridorhenium(V) Complexes with Five-Membered N-Heteroaromatic Ligands and Photoluminescence-Intensity Change

por Seike, Moe, Nagata, Kojiro, Ikeda, Hayato, Ito, Akitaka, Sakuda, Eri, Kitamura, Noboru, Shinohara, Atsushi, Yoshimura, Takashi
Publicado no ACS Omega (2019)

First determination of Pu isotopes ((239)Pu, (240)Pu and (241)Pu) in radioactive particles derived from Fukushima Daiichi Nuclear Power Plant accident

por Igarashi, Junya, Zheng, Jian, Zhang, Zijian, Ninomiya, Kazuhiko, Satou, Yukihiko, Fukuda, Miho, Ni, Youyi, Aono, Tatsuo, Shinohara, Atsushi
Publicado no Sci Rep (2019)

Feasibility studies towards future self-sufficient supply of the (99)Mo-(99m)Tc isotopes with Japanese accelerators

por NAKAI, Kozi, TAKAHASHI, Naruto, HATAZAWA, Jun, SHINOHARA, Atsushi, HAYASHI, Yoshihiko, IKEDA, Hayato, KANAI, Yasukazu, WATABE, Tadashi, FUKUDA, Mitsuhiro, HATANAKA, Kichiji
Publicado no Proc Jpn Acad Ser B Phys Biol Sci (2014)

Enhancement of (211)At Uptake via the Sodium Iodide Symporter by the Addition of Ascorbic Acid in Targeted α-Therapy of Thyroid Cancer

por Watabe, Tadashi, Kaneda-Nakashima, Kazuko, Liu, Yuwei, Shirakami, Yoshifumi, Ooe, Kazuhiro, Toyoshima, Atsushi, Shimosegawa, Eku, Fukuda, Mitsuhiro, Shinohara, Atsushi, Hatazawa, Jun
Publicado no J Nucl Med (2019)

Preclinical Evaluation of Radiation-Induced Toxicity in Targeted Alpha Therapy Using [(211)At] NaAt in Mice: A Revisit()

por Liu, Yuwei, Watabe, Tadashi, Kaneda-Nakashima, Kazuko, Ooe, Kazuhiro, Shirakami, Yoshifumi, Toyoshima, Atsushi, Shimosegawa, Eku, Nakano, Takashi, Shinohara, Atsushi, Hatazawa, Jun
Publicado no Transl Oncol (2020)

Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy

por Kato, Hiroki, Huang, Xuhao, Kadonaga, Yuichiro, Katayama, Daisuke, Ooe, Kazuhiro, Shimoyama, Atsushi, Kabayama, Kazuya, Toyoshima, Atsushi, Shinohara, Atsushi, Hatazawa, Jun, Fukase, Koichi
Publicado no J Nanobiotechnology (2021)

Synthesis of [(211)At]4-astato-L-phenylalanine by dihydroxyboryl-astatine substitution reaction in aqueous solution

por Shirakami, Yoshifumi, Watabe, Tadashi, Obata, Honoka, Kaneda, Kazuko, Ooe, Kazuhiro, Liu, Yuwei, Teramoto, Takahiro, Toyoshima, Atsushi, Shinohara, Atsushi, Shimosegawa, Eku, Hatazawa, Jun, Fukase, Koichi
Publicado no Sci Rep (2021)

Targeted alpha therapy using astatine ((211)At)-labeled phenylalanine: A preclinical study in glioma bearing mice

por Watabe, Tadashi, Kaneda-Nakashima, Kazuko, Shirakami, Yoshifumi, Liu, Yuwei, Ooe, Kazuhiro, Teramoto, Takahiro, Toyoshima, Atsushi, Shimosegawa, Eku, Nakano, Takashi, Kanai, Yoshikatsu, Shinohara, Atsushi, Hatazawa, Jun
Publicado no Oncotarget (2020)

Extended single-dose toxicity study of [(211)At]NaAt in mice for the first-in-human clinical trial of targeted alpha therapy for differentiated thyroid cancer

por Watabe, Tadashi, Kaneda-Nakashima, Kazuko, Ooe, Kazuhiro, Liu, Yuwei, Kurimoto, Kenta, Murai, Takashi, Shidahara, Yuka, Okuma, Kenji, Takeuchi, Masanori, Nishide, Masayuki, Toyoshima, Atsushi, Shinohara, Atsushi, Shirakami, Yoshifumi
Publicado no Ann Nucl Med (2021)

Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: (64)Cu- and (225)Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models

por Watabe, Tadashi, Liu, Yuwei, Kaneda-Nakashima, Kazuko, Shirakami, Yoshifumi, Lindner, Thomas, Ooe, Kazuhiro, Toyoshima, Atsushi, Nagata, Kojiro, Shimosegawa, Eku, Haberkorn, Uwe, Kratochwil, Clemens, Shinohara, Atsushi, Giesel, Frederik, Hatazawa, Jun
Publicado no J Nucl Med (2020)

α‐Emitting cancer therapy using (211)At‐AAMT targeting LAT1

por Kaneda‐Nakashima, Kazuko, Zhang, ZiJian, Manabe, Yoshiyuki, Shimoyama, Atsushi, Kabayama, Kazuya, Watabe, Tadashi, Kanai, Yoshikatsu, Ooe, Kazuhiro, Toyoshima, Atsushi, Shirakami, Yoshifumi, Yoshimura, Takashi, Fukuda, Mitsuhiro, Hatazawa, Jun, Nakano, Takashi, Fukase, Koichi, Shinohara, Atsushi
Publicado no Cancer Sci (2021)

Structural and compositional characteristics of Fukushima release particulate material from Units 1 and 3 elucidates release mechanisms, accident chronology and future decommission...

por Martin, Peter G., Jones, Christopher P., Bartlett, Stuart, Ignatyev, Konstantin, Megson-Smith, Dave, Satou, Yukihiko, Cipiccia, Silvia, Batey, Darren J., Rau, Christoph, Sueki, Keisuke, Ishii, Tatsuya, Igarashi, Junya, Ninomiya, Kazuhiko, Shinohara, Atsushi, Rust, Alison, Scott, Thomas B.
Publicado no Sci Rep (2020)